A pilot study of gemcitabine (g), oxaliplatin (o), cetuximab (c) for locally advanced or metastatic pancreatic cancer
Jaime R. Merchan(Sylvester Comprehensive Cancer Center), Caio Rocha‐Lima(University of Miami), Afonso Ribeiro(University of Miami), Kristen K. Ciombor(Vanderbilt University Medical Center), Michel Vulfovich(Memorial Healthcare System), Jessica MacIntyre, F. Aurea, Danny Sleeman(University of Miami), A. Venkatraman, Joé U. Levi
Cited by 3
Related Papers
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|998
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|846
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2024|333
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024
|Journal of the National Comprehensive Cancer Network|2024|244